Today on DrugResearcher.com   Targeted Genetics restarts trial after death Paediatric drugs and testing highlighted Exploring protein interactions in 'technicolour' Pharma should keep outsourcing in mind Preclinical services news in brief

Related Industry News   MHRA launches new action plan to combat UK counterfeit hub Schott takes aim at Russia Regulators slate Roche 'lack of knowledge and understanding' in Viracept contamination case GSK buys Reliant for cardiovascular drugs

Breaking News on Drug Discovery
Daily  Monday 26 November 2007		Forward to a colleague

	Sponsored Link CappAero pipettes - ultimate accuracy and intelligent design The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here Access Full Stories Targeted Genetics restarts trial after death The US Food and Drug Administration has allowed Targeted Genetics to restart testing its arthritis gene therapy after deciding the drug wasn't at fault when one person died in the original clinical trial... Read Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego... Read Exploring protein interactions in 'technicolour' A triple-colour bioluminescent assay has been developed that promises to speed-up high content screening (HCS) analysis by enabling multiple-target monitoring... Read Pharma should keep outsourcing in mind The pharmaceutical industry is backward when it comes to outsourcing, industry experts said at the American Association of Pharmaceutical Scientists (AAPS) conference in San Diego last week... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving ChemDiv, SRI International, ShangPharma, Ranbaxy and Xceleron... Read
	All News Headlines for: November | October | September
	Related Industry News MHRA launches new action plan to combat UK counterfeit hub The UK has become an unlikely hub for drug counterfeiters, with the UK Medicines and Healthcare products Regulatory Agency (MHRA) last week launching its new three-year action plan to tackle the recent surge in... Read Schott takes aim at Russia Pharmaceutical packaging specialist Schott has announced plans to head to Russia and establish its first pharma production site in the country... Read Regulators slate Roche 'lack of knowledge and understanding' in Viracept contamination case The official report into good manufacturing practice (GMP) failures that caused dangerous contamination and a Europe-wide recall of Roche's HIV drug Viracept (nelfinavir) claims the firm simply did not understand... Read GSK buys Reliant for cardiovascular drugs GlaxoSmithKline (GSK) has acquired Reliant Pharmaceuticals for $1.65bn in a bid to improve its cardiovascular therapy portfolio... Read Weekly Comment South Africa 'underutilised' for clinical trials While India, the Asia-Pacific, Eastern Europe and Latin America are all gaining recognition as potential new hot spots, South Africa remains 'underutilised as a clinical trial destination,' according to a prominent industry figure. Read Previous Headlines Merck, Vertex halt aurora kinase cancer trial Merck & Co. and its partner Vertex Pharmaceuticals have stopped enrolling cancer patients to the clinical trial of its aurora kinase trial after one patient suffered heart problems... Read Mr Gene designs and orders constructs in minutes Geneart has launched the first fully on-line gene construct design and ordering system, dubbed Mr Gene, which is targeting the emerging 'low-price' segment of the synthetic biology market... Read Take off immune system brake to improve cancer vaccines The discovery of a new molecule that can act as a brake for the immune system could lead to new therapies for cancer and autoimmune diseases such as diabetes... Read Drugs moving into the clinic: 36 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read New research offers CRO market snapshot New research from Frost & Sullivan provides a snapshot of biopharma spending trends on contract research organisations (CROs), along with forecasts for industry growth... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com